Press "Enter" to skip to content

New patent for Teva Pharm drug AIRDUO RESPICLICK

0
Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug AIRDUO RESPICLICK

Annual Drug Patent Expirations for AIRDUO+RESPICLICK
Annual Drug Patent Expirations for AIRDUO+RESPICLICK

Airduo Respiclick is a drug marketed by Teva Pharm
and is included in one NDA. It is available from two suppliers. There are fifteen patents protecting this drug.

This drug has two hundred and ninety-six patent family members in thirty-two countries.

The generic ingredient in AIRDUO RESPICLICK is fluticasone propionate; salmeterol xinafoate. Two suppliers are listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug AIRDUO RESPICLICK
Do NOT follow this link or you will be banned from the site!